Medical Care

Global PD-L1 Biomarker Testing Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

The global PD-L1 Biomarker Testing market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Agilent Technologies
Roche
Merck
Bristol-Myers Squibb
AstraZeneca
Ono Pharmaceutical
Regeneron
Innovent
Hengrui Medicine
Junshi Biosciences
By Type: (Dominant Segment vs High-Margin Innovation)
PD-L1 (22C3)
PD-L1(28-8)
PD-L1 (SP142)
PD-L1 (SP263)
Other
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital
Diagnostic Center
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Agilent Technologies in Europe)
- Emerging Product Trends: PD-L1 (22C3) adoption vs. PD-L1(28-8) premiumization
- Demand-Side Dynamics: Hospital growth in China vs. Diagnostic Center potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Asia-Pacific
Europe
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of PD-L1 Biomarker Testing market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., PD-L1(28-8) in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Diagnostic Center in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the PD-L1 Biomarker Testing value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 PD-L1 (22C3)
1.2.3 PD-L1(28-8)
1.2.4 PD-L1 (SP142)
1.2.5 PD-L1 (SP263)
1.2.6 Other
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global PD-L1 Biomarker Testing Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global PD-L1 Biomarker Testing Revenue Market Share by Region (2020-2025)
2.4 Global PD-L1 Biomarker Testing Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America PD-L1 Biomarker Testing Market Size and Prospective (2020-2031)
2.5.2 Asia-Pacific PD-L1 Biomarker Testing Market Size and Prospective (2020-2031)
2.5.3 Europe PD-L1 Biomarker Testing Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global PD-L1 Biomarker Testing Historic Market Size by Type (2020-2025)
3.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2026-2031)
3.3 Different Types PD-L1 Biomarker Testing Representative Players
4 Breakdown Data by Application
4.1 Global PD-L1 Biomarker Testing Historic Market Size by Application (2020-2025)
4.2 Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in PD-L1 Biomarker Testing Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top PD-L1 Biomarker Testing Players by Revenue (2020-2025)
5.1.2 Global PD-L1 Biomarker Testing Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by PD-L1 Biomarker Testing Revenue
5.4 Global PD-L1 Biomarker Testing Market Concentration Analysis
5.4.1 Global PD-L1 Biomarker Testing Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by PD-L1 Biomarker Testing Revenue in 2024
5.5 Global Key Players of PD-L1 Biomarker Testing Head office and Area Served
5.6 Global Key Players of PD-L1 Biomarker Testing, Product and Application
5.7 Global Key Players of PD-L1 Biomarker Testing, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America PD-L1 Biomarker Testing Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America PD-L1 Biomarker Testing Market Size by Type (2020-2025)
6.1.2.2 North America PD-L1 Biomarker Testing Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America PD-L1 Biomarker Testing Market Size by Application (2020-2025)
6.1.3.2 North America PD-L1 Biomarker Testing Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Asia-Pacific Market: Players, Segments and Downstream
6.2.1 Asia-Pacific PD-L1 Biomarker Testing Revenue by Company (2020-2025)
6.2.2 Asia-Pacific Market Size by Type
6.2.2.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2020-2025)
6.2.2.2 Asia-Pacific PD-L1 Biomarker Testing Market Share by Type (2020-2025)
6.2.3 Asia-Pacific Market Size by Application
6.2.3.1 Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2020-2025)
6.2.3.2 Asia-Pacific PD-L1 Biomarker Testing Market Share by Application (2020-2025)
6.2.4 Asia-Pacific Market Trend and Opportunities
6.3 Europe Market: Players, Segments and Downstream
6.3.1 Europe PD-L1 Biomarker Testing Revenue by Company (2020-2025)
6.3.2 Europe Market Size by Type
6.3.2.1 Europe PD-L1 Biomarker Testing Market Size by Type (2020-2025)
6.3.2.2 Europe PD-L1 Biomarker Testing Market Share by Type (2020-2025)
6.3.3 Europe Market Size by Application
6.3.3.1 Europe PD-L1 Biomarker Testing Market Size by Application (2020-2025)
6.3.3.2 Europe PD-L1 Biomarker Testing Market Share by Application (2020-2025)
6.3.4 Europe Market Trend and Opportunities
7 Key Players Profiles
7.1 Agilent Technologies
7.1.1 Agilent Technologies Company Details
7.1.2 Agilent Technologies Business Overview
7.1.3 Agilent Technologies PD-L1 Biomarker Testing Introduction
7.1.4 Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2020-2025)
7.1.5 Agilent Technologies Recent Development
7.2 Roche
7.2.1 Roche Company Details
7.2.2 Roche Business Overview
7.2.3 Roche PD-L1 Biomarker Testing Introduction
7.2.4 Roche Revenue in PD-L1 Biomarker Testing Business (2020-2025)
7.2.5 Roche Recent Development
7.3 Merck
7.3.1 Merck Company Details
7.3.2 Merck Business Overview
7.3.3 Merck PD-L1 Biomarker Testing Introduction
7.3.4 Merck Revenue in PD-L1 Biomarker Testing Business (2020-2025)
7.3.5 Merck Recent Development
7.4 Bristol-Myers Squibb
7.4.1 Bristol-Myers Squibb Company Details
7.4.2 Bristol-Myers Squibb Business Overview
7.4.3 Bristol-Myers Squibb PD-L1 Biomarker Testing Introduction
7.4.4 Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2020-2025)
7.4.5 Bristol-Myers Squibb Recent Development
7.5 AstraZeneca
7.5.1 AstraZeneca Company Details
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca PD-L1 Biomarker Testing Introduction
7.5.4 AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2020-2025)
7.5.5 AstraZeneca Recent Development
7.6 Ono Pharmaceutical
7.6.1 Ono Pharmaceutical Company Details
7.6.2 Ono Pharmaceutical Business Overview
7.6.3 Ono Pharmaceutical PD-L1 Biomarker Testing Introduction
7.6.4 Ono Pharmaceutical Revenue in PD-L1 Biomarker Testing Business (2020-2025)
7.6.5 Ono Pharmaceutical Recent Development
7.7 Regeneron
7.7.1 Regeneron Company Details
7.7.2 Regeneron Business Overview
7.7.3 Regeneron PD-L1 Biomarker Testing Introduction
7.7.4 Regeneron Revenue in PD-L1 Biomarker Testing Business (2020-2025)
7.7.5 Regeneron Recent Development
7.8 Innovent
7.8.1 Innovent Company Details
7.8.2 Innovent Business Overview
7.8.3 Innovent PD-L1 Biomarker Testing Introduction
7.8.4 Innovent Revenue in PD-L1 Biomarker Testing Business (2020-2025)
7.8.5 Innovent Recent Development
7.9 Hengrui Medicine
7.9.1 Hengrui Medicine Company Details
7.9.2 Hengrui Medicine Business Overview
7.9.3 Hengrui Medicine PD-L1 Biomarker Testing Introduction
7.9.4 Hengrui Medicine Revenue in PD-L1 Biomarker Testing Business (2020-2025)
7.9.5 Hengrui Medicine Recent Development
7.10 Junshi Biosciences
7.10.1 Junshi Biosciences Company Details
7.10.2 Junshi Biosciences Business Overview
7.10.3 Junshi Biosciences PD-L1 Biomarker Testing Introduction
7.10.4 Junshi Biosciences Revenue in PD-L1 Biomarker Testing Business (2020-2025)
7.10.5 Junshi Biosciences Recent Development
8 PD-L1 Biomarker Testing Market Dynamics
8.1 PD-L1 Biomarker Testing Industry Trends
8.2 PD-L1 Biomarker Testing Market Drivers
8.3 PD-L1 Biomarker Testing Market Challenges
8.4 PD-L1 Biomarker Testing Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global PD-L1 Biomarker Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global PD-L1 Biomarker Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market PD-L1 Biomarker Testing Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global PD-L1 Biomarker Testing Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global PD-L1 Biomarker Testing Revenue Share by Region (2020-2025)
Table 6. Global PD-L1 Biomarker Testing Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global PD-L1 Biomarker Testing Revenue Share Forecast by Region (2026-2031)
Table 8. Global PD-L1 Biomarker Testing Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2020-2025)
Table 10. Global PD-L1 Biomarker Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global PD-L1 Biomarker Testing Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global PD-L1 Biomarker Testing Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global PD-L1 Biomarker Testing Revenue Market Share by Application (2020-2025)
Table 15. Global PD-L1 Biomarker Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global PD-L1 Biomarker Testing Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in PD-L1 Biomarker Testing Application
Table 18. Global PD-L1 Biomarker Testing Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global PD-L1 Biomarker Testing Market Share by Players (2020-2025)
Table 20. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2024)
Table 21. Ranking of Global Top PD-L1 Biomarker Testing Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by PD-L1 Biomarker Testing Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of PD-L1 Biomarker Testing, Headquarters and Area Served
Table 24. Global Key Players of PD-L1 Biomarker Testing, Product and Application
Table 25. Global Key Players of PD-L1 Biomarker Testing, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America PD-L1 Biomarker Testing Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America PD-L1 Biomarker Testing Revenue Market Share by Company (2020-2025)
Table 29. North America PD-L1 Biomarker Testing Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America PD-L1 Biomarker Testing Market Size by Application (2020-2025) & (US$ Million)
Table 31. Asia-Pacific PD-L1 Biomarker Testing Revenue by Company (2020-2025) & (US$ Million)
Table 32. Asia-Pacific PD-L1 Biomarker Testing Revenue Market Share by Company (2020-2025)
Table 33. Asia-Pacific PD-L1 Biomarker Testing Market Size by Type (2020-2025) & (US$ Million)
Table 34. Asia-Pacific PD-L1 Biomarker Testing Market Size by Application (2020-2025) & (US$ Million)
Table 35. Europe PD-L1 Biomarker Testing Revenue by Company (2020-2025) & (US$ Million)
Table 36. Europe PD-L1 Biomarker Testing Revenue Market Share by Company (2020-2025)
Table 37. Europe PD-L1 Biomarker Testing Market Size by Type (2020-2025) & (US$ Million)
Table 38. Europe PD-L1 Biomarker Testing Market Size by Application (2020-2025) & (US$ Million)
Table 39. Agilent Technologies Company Details
Table 40. Agilent Technologies Business Overview
Table 41. Agilent Technologies PD-L1 Biomarker Testing Product
Table 42. Agilent Technologies Revenue in PD-L1 Biomarker Testing Business (2020-2025) & (US$ Million)
Table 43. Agilent Technologies Recent Development
Table 44. Roche Company Details
Table 45. Roche Business Overview
Table 46. Roche PD-L1 Biomarker Testing Product
Table 47. Roche Revenue in PD-L1 Biomarker Testing Business (2020-2025) & (US$ Million)
Table 48. Roche Recent Development
Table 49. Merck Company Details
Table 50. Merck Business Overview
Table 51. Merck PD-L1 Biomarker Testing Product
Table 52. Merck Revenue in PD-L1 Biomarker Testing Business (2020-2025) & (US$ Million)
Table 53. Merck Recent Development
Table 54. Bristol-Myers Squibb Company Details
Table 55. Bristol-Myers Squibb Business Overview
Table 56. Bristol-Myers Squibb PD-L1 Biomarker Testing Product
Table 57. Bristol-Myers Squibb Revenue in PD-L1 Biomarker Testing Business (2020-2025) & (US$ Million)
Table 58. Bristol-Myers Squibb Recent Development
Table 59. AstraZeneca Company Details
Table 60. AstraZeneca Business Overview
Table 61. AstraZeneca PD-L1 Biomarker Testing Product
Table 62. AstraZeneca Revenue in PD-L1 Biomarker Testing Business (2020-2025) & (US$ Million)
Table 63. AstraZeneca Recent Development
Table 64. Ono Pharmaceutical Company Details
Table 65. Ono Pharmaceutical Business Overview
Table 66. Ono Pharmaceutical PD-L1 Biomarker Testing Product
Table 67. Ono Pharmaceutical Revenue in PD-L1 Biomarker Testing Business (2020-2025) & (US$ Million)
Table 68. Ono Pharmaceutical Recent Development
Table 69. Regeneron Company Details
Table 70. Regeneron Business Overview
Table 71. Regeneron PD-L1 Biomarker Testing Product
Table 72. Regeneron Revenue in PD-L1 Biomarker Testing Business (2020-2025) & (US$ Million)
Table 73. Regeneron Recent Development
Table 74. Innovent Company Details
Table 75. Innovent Business Overview
Table 76. Innovent PD-L1 Biomarker Testing Product
Table 77. Innovent Revenue in PD-L1 Biomarker Testing Business (2020-2025) & (US$ Million)
Table 78. Innovent Recent Development
Table 79. Hengrui Medicine Company Details
Table 80. Hengrui Medicine Business Overview
Table 81. Hengrui Medicine PD-L1 Biomarker Testing Product
Table 82. Hengrui Medicine Revenue in PD-L1 Biomarker Testing Business (2020-2025) & (US$ Million)
Table 83. Hengrui Medicine Recent Development
Table 84. Junshi Biosciences Company Details
Table 85. Junshi Biosciences Business Overview
Table 86. Junshi Biosciences PD-L1 Biomarker Testing Product
Table 87. Junshi Biosciences Revenue in PD-L1 Biomarker Testing Business (2020-2025) & (US$ Million)
Table 88. Junshi Biosciences Recent Development
Table 89. PD-L1 Biomarker Testing Market Trends
Table 90. PD-L1 Biomarker Testing Market Drivers
Table 91. PD-L1 Biomarker Testing Market Challenges
Table 92. PD-L1 Biomarker Testing Market Restraints
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources


List of Figures
Figure 1. PD-L1 Biomarker Testing Product Picture
Figure 2. Global PD-L1 Biomarker Testing Market Share by Type: 2024 VS 2031
Figure 3. PD-L1 (22C3) Features
Figure 4. PD-L1(28-8) Features
Figure 5. PD-L1 (SP142) Features
Figure 6. PD-L1 (SP263) Features
Figure 7. Other Features
Figure 8. Global PD-L1 Biomarker Testing Market Share by Application: 2024 VS 2031
Figure 9. Hospital
Figure 10. Diagnostic Center
Figure 11. Others
Figure 12. PD-L1 Biomarker Testing Report Years Considered
Figure 13. Global PD-L1 Biomarker Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global PD-L1 Biomarker Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global PD-L1 Biomarker Testing Revenue Market Share by Region: 2020 VS 2024
Figure 16. North America PD-L1 Biomarker Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. Asia-Pacific PD-L1 Biomarker Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Europe PD-L1 Biomarker Testing Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Global PD-L1 Biomarker Testing Market Share by Players in 2024
Figure 20. Global Top PD-L1 Biomarker Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in PD-L1 Biomarker Testing as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by PD-L1 Biomarker Testing Revenue in 2024
Figure 22. North America PD-L1 Biomarker Testing Market Share by Type (2020-2025)
Figure 23. North America PD-L1 Biomarker Testing Market Share by Application (2020-2025)
Figure 24. Asia-Pacific PD-L1 Biomarker Testing Market Share by Type (2020-2025)
Figure 25. Asia-Pacific PD-L1 Biomarker Testing Market Share by Application (2020-2025)
Figure 26. Europe PD-L1 Biomarker Testing Market Share by Type (2020-2025)
Figure 27. Europe PD-L1 Biomarker Testing Market Share by Application (2020-2025)
Figure 28. Agilent Technologies Revenue Growth Rate in PD-L1 Biomarker Testing Business (2020-2025)
Figure 29. Roche Revenue Growth Rate in PD-L1 Biomarker Testing Business (2020-2025)
Figure 30. Merck Revenue Growth Rate in PD-L1 Biomarker Testing Business (2020-2025)
Figure 31. Bristol-Myers Squibb Revenue Growth Rate in PD-L1 Biomarker Testing Business (2020-2025)
Figure 32. AstraZeneca Revenue Growth Rate in PD-L1 Biomarker Testing Business (2020-2025)
Figure 33. Ono Pharmaceutical Revenue Growth Rate in PD-L1 Biomarker Testing Business (2020-2025)
Figure 34. Regeneron Revenue Growth Rate in PD-L1 Biomarker Testing Business (2020-2025)
Figure 35. Innovent Revenue Growth Rate in PD-L1 Biomarker Testing Business (2020-2025)
Figure 36. Hengrui Medicine Revenue Growth Rate in PD-L1 Biomarker Testing Business (2020-2025)
Figure 37. Junshi Biosciences Revenue Growth Rate in PD-L1 Biomarker Testing Business (2020-2025)
Figure 38. Bottom-up and Top-down Approaches for This Report
Figure 39. Data Triangulation
Figure 40. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies